E-cadherin breast tumor expression, risk factors and survival: Pooled analysis of 5,933 cases from 12 studies in the Breast Cancer Association Consortium von Horne, H.N., Oh, H., Sherman, M.E., Palakal, M., Hewitt, S.M., Schmidt, M.K., Milne, R.L., Hardisson, D., Benitez, J., Blomqvist, C., Bolla, M.K., Brenner, H., Chang-Claude, J., Cora, R., Couch, F.J., Cuk, K., Devilee, P., Easton, D.F., Eccles, D.M., Eilber, U., Hartikainen, J.M., Heikkila, P., Holleczek, B., Hooning, M.J., Jones, M., Keeman, R., Mannermaa, A., Martens, J.W.M., Muranen, T.A., Nevanlinna, H., Olson, J.E., Orr, N., Perez, J.I.A., Pharoah, P.D.P., Ruddy, K.J., Saum, K.U., Schoemaker, M.J., Seynaeve, C., Sironen, R., Smit, V.T.H.B.M., Swerdlow, A.J., Tengstrom, M., Thomas, A.S., Timmermans, A.M., Tollenaar, R.A.E.M., Troester, M.A., Asperen, C.J. van, Deurzen, C.H.M. van, Leeuwen, F.F. van, Van'tVeer, L.J., Garcia-Closas, M., Figueroa, J.D.

Volltext bestellen

N‐myc suppresses major histocompatibility complex class I gene expression through down‐regulation of the p50 subunit of NF‐kappa B von Veer, L.J., Beijersbergen, R.L., Bernards, R.

Volltext

Acute lymphoblastic leukaemia in adults : immunological subtypes and clinical features at presentation von VAN'T VEER, M. B, VAN PUTTEN, W. L. J, VERDONCK, L. F, OSSENKOPPELE, G. J, LÖWENBERG, B, KLUIN-NELEMANS, J. C, WIJERMANS, P. W, SCHOUTEN, H. C, SIZOO, W, DEKKER, A. W

Volltext